These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7298981)

  • 21. Cutaneous carcinoma with mixed histology: a potential etiology for skin cancer recurrence and an indication for Mohs microscopically controlled surgical excision.
    Cohen PR; Schulze KE; Nelson BR
    South Med J; 2005 Jul; 98(7):740-7. PubMed ID: 16108247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.
    Rowe DE; Carroll RJ; Day CL
    J Dermatol Surg Oncol; 1989 Apr; 15(4):424-31. PubMed ID: 2925988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mohs' micrographic surgery for basal cell carcinoma.
    Lawrence CM
    Clin Exp Dermatol; 1999 Mar; 24(2):130-3. PubMed ID: 10233670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic evolution of recurrent basal cell carcinoma and treatment implications.
    Lang PG; Maize JC
    J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):186-96. PubMed ID: 3950119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management.
    Codazzi D; Van Der Velden J; Carminati M; Bruschi S; Bocchiotti MA; Di Serio C; Barberis M; Robotti E
    J Plast Surg Hand Surg; 2014 Feb; 48(1):38-43. PubMed ID: 23731130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surgical treatment of basaliomas with calculated safety margin and control of the histologic borders. Experiences with 355 tumors].
    Breuninger H; Rassner G; Undeutsch W
    Hautarzt; 1984 Jun; 35(6):303-7. PubMed ID: 6469635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in the presentation and treatment of basal cell carcinomas.
    Roenigk RK; Ratz JL; Bailin PL; Wheeland RG
    J Dermatol Surg Oncol; 1986 Aug; 12(8):860-5. PubMed ID: 3734238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mohs' chemosurgery and skin cancer.
    Olshansky K; Robins P
    South Med J; 1976 Sep; 69(9):1126-7. PubMed ID: 968524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
    Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
    J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rationale for the treatment of difficult basal cell and squamous cell carcinomas of the skin.
    Riefkohl R; Pollack S; Georgiade GS
    Ann Plast Surg; 1985 Aug; 15(2):99-104. PubMed ID: 3911860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole specimen intraoperative frozen section analysis. Experience with 1082 basal cell carcinomas.
    Kedilioglu MA; Bos PG; De Jong K; Noordzij NA; Kibbelaar RE; Lapid O; Mouës CM
    Eur J Surg Oncol; 2018 Jan; 44(1):157-162. PubMed ID: 29198817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of Mohs' micrographic surgery in two English centres.
    Julian CG; Bowers PW
    Br J Dermatol; 1997 Apr; 136(4):515-8. PubMed ID: 9155950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mohs' surgery, fresh-tissue technique. Our technique with a review.
    Cottel WI; Proper S
    J Dermatol Surg Oncol; 1982 Jul; 8(7):576-87. PubMed ID: 6181110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.
    Armstrong LTD; Magnusson MR; Guppy MPB
    J Plast Reconstr Aesthet Surg; 2017 Dec; 70(12):1738-1745. PubMed ID: 28579037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term recurrence rates of whole specimen intraoperative frozen section analysis in basal cell carcinomas of the face with WIFSA.
    Scholten LA; Kedilioglu MA; Huizinga PM; Kibbelaar RE; de Jong K; Mouës CM
    J Surg Oncol; 2019 Jun; 119(7):903-908. PubMed ID: 30737791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision.
    Silverman MK; Kopf AW; Bart RS; Grin CM; Levenstein MS
    J Dermatol Surg Oncol; 1992 Jun; 18(6):471-6. PubMed ID: 1592998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small margin excision of periocular basal cell carcinomas.
    Chadha V; Wright M
    Br J Ophthalmol; 2009 Jun; 93(6):803-6. PubMed ID: 19304655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.